AVEO Seeks FDA Approval for Drug Designed to Treat Advanced Kidney Cancer

AVEO Oncology of Cambridge and Japanese drug maker Astellas Pharma Inc. said Friday that AVEO has submitted a new drug application to the US Food and Drug Administration for a potential treatment for advanced kidney cancer.
Boston Globe